Healthcare
Monday, September 5, 2016
BRIEF-Biocartis Group H1 net loss widens to 23.8 million euros
* Cash and cash equivalents at the end of H1 75.8 million
euros ($84.49 million) versus 128.5 million euros year ago
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment